| Mrs Deborah Rejent, PHD, MSSW, LCSW-C | |
|
1050 Key Parkway, Suite 103, Frederick, MD 21702-4496 | |
| (240) 629-3939 | |
| Not Available |
| Full Name | Mrs Deborah Rejent |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1050 Key Parkway, Frederick, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295121879 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Deborah Rejent, PHD, MSSW, LCSW-C Po Box 2348, Germantown, MD 20875-2348 Ph: (240) 629-3912 | Mrs Deborah Rejent, PHD, MSSW, LCSW-C 1050 Key Parkway, Suite 103, Frederick, MD 21702-4496 Ph: (240) 629-3939 |
News Archive
Our brain is a high-performance computer. One of the key players in this complex system is the AMPA-type glutamate receptor. It ensures that neurotransmission proceeds at a breakneck pace from cell to cell.
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
An experimental vaccine based on a virus that causes encephalitis in the wild appears to block tumor growth in some cases of advanced cancer, according to researchers at Duke University Medical Center. Scientists say the vaccine is able to stimulate an immune response, even in the face of profound immune system suppression, a condition most patients with advanced cancer experience.
Nymox Pharmaceutical Corporation is pleased to report positive new results from the 30-36 month follow-up study of patients treated with NX-1207 in Study NX02-0016. The initial study, completed in the U.S. in 2007, reached statistical significance in Intent-to-Treat Primary Efficacy outcomes at 90 days and 6 months post-treatment with NX-1207 2.5 mg.
Inergetics, Inc., a leader in targeted product development for the Clinical Nutrition and Sports Supplement Markets, today announced that the Company has received a $112,500 purchase order for Resurgex Select from New Marketlink Pharmaceutical Corporation "New Marketlink."
› Verified 9 days ago
Ms. Paula Grace, LCSW C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7190 Crestwood Blvd, Kaiser Permanente Frederick Medical Center, Frederick, MD 21703 Phone: 240-529-1700 | |
John Paul Mulhern, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 309 E Patrick St, Frederick, MD 21701 Phone: 301-631-1304 Fax: 301-631-1384 | |
Dr. Michael W. Stern, PH.D. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 170 Thomas Johnson Dr, Ste 200, Frederick, MD 21702 Phone: 301-695-8390 Fax: 301-694-7906 | |
Mrs. Meredith Andrews Mcadam, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 905 W 7th St, Pmb 293, Frederick, MD 21701 Phone: 240-575-1810 Fax: 301-591-4114 | |
Siehda Sutton Parker, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 5301 Buckeystown Pike Ste 320, Frederick, MD 21704 Phone: 540-322-5424 Fax: 617-807-0958 | |
Ms. Sandra L Lake, L.C.S.W.-C. Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 350 Montevue Ln, Frederick, MD 21702 Phone: 301-600-1755 Fax: 301-600-3214 | |
Caitlin Meehan Williams, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 300 W 9th St, Frederick, MD 21701 Phone: 667-600-3367 |